documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
101 rows where agency_id = "FDA", document_type = "Rule" and posted_year = 2008 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, comment_end_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2008-N-0039-0091 | FDA | FDA-2008-N-0039 | Ophthalmic and Topical Dosage Form New Animal Drugs; Triamcinolone Cream | Rule | Final Rule | 2008-12-29T05:00:00Z | 2008 | 12 | 2008-12-29T05:00:00Z | 2013-07-09T18:48:19Z | E8-30694 | 0 | 0 | 0900006480805eeb | |
| FDA-2008-S-0350-0001 | FDA | FDA-2008-S-0350 | Food Additives Permitted in Feed and Drinking Water of Animals | Rule | NCR-Notice of Correction | 2008-12-24T05:00:00Z | 2008 | 12 | 2008-12-24T05:00:00Z | 2008-12-24T17:44:31Z | E8-30840 | 0 | 0 | 09000064807f8dc4 | |
| FDA-2000-N-0011-0004 | FDA | Uniform Compliance Date for Food Labeling Regulations FDA-2000-N-0011 | Uniform Compliance Date for Food Labeling Regulations, January 2, 2012 | Rule | NFR-Notice of Final Rule | 2008-12-08T05:00:00Z | 2008 | 12 | 2008-12-08T05:00:00Z | 2009-02-24T04:59:59Z | 2009-01-08T16:17:38Z | E8-28920 | 0 | 0 | 09000064807d2029 |
| FDA-2008-N-0039-0082 | FDA | FDA-2008-N-0039 | New Animal Drugs; Ractopamine | Rule | Final Rule | 2008-12-01T05:00:00Z | 2008 | 12 | 2008-12-01T05:00:00Z | 2013-07-10T16:15:59Z | E8-28384 | 0 | 0 | 09000064807c7111 | |
| FDA-2008-N-0326-0176 | FDA | FDA-2008-N-0326 | New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Revocation of Order of Prohibition; Withdrawal | Rule | NWL-Notice of Withdrawl | 2008-11-26T05:00:00Z | 2008 | 11 | 2008-11-26T05:00:00Z | 2008-12-20T16:26:21Z | E8-28093 | 0 | 0 | 09000064807c1087 | |
| FDA-2008-N-0039-0081 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Amprolium; Correction | Rule | Correction | 2008-11-20T05:00:00Z | 2008 | 11 | 2008-11-20T05:00:00Z | 2013-07-11T14:19:15Z | E8-27646 | 0 | 0 | 09000064807b36b5 | |
| FDA-2007-N-0314-0044 | FDA | FDA-2007-N-0314 | Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine) - Notice of Final Rule | Rule | NFR-Notice of Final Rule | 2008-11-19T05:00:00Z | 2008 | 11 | 2008-11-19T05:00:00Z | 2011-06-11T16:26:51Z | E8-27436 | 0 | 0 | 09000064807b155a | |
| FDA-2006-N-0364-0007 | FDA | Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile FDA-2006-N-0364 | Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile; Technical Amendment | Rule | Final Rule | 2008-11-18T05:00:00Z | 2008 | 11 | 2008-11-18T05:00:00Z | 2015-11-12T18:01:15Z | E8-27254 | 0 | 0 | 09000064807af926 | |
| FDA-2008-N-0561-0002 | FDA | FDA-2008-N-0561 | Maximum Civil Money Penalty Amounts and Compliance with the Federal Civil Penalties Inflation Adjustment Act | Rule | NFR-Notice of Final Rule | 2008-11-12T05:00:00Z | 2008 | 11 | 2008-11-12T05:00:00Z | 2009-01-27T04:59:59Z | 2009-01-22T18:45:33Z | E8-26866 | 0 | 0 | 09000064807a4dd5 |
| FDA-2004-N-0511-0005 | FDA | Obstetrical and Gynecological Devices; Designation of Special Controls for Male Condoms Made of Natural Rubber Latex FDA-2004-N-0511 | Obstetrical and Gynecological Devices; Designation of Special Controls for Male Condoms Made of Natural Rubber Latex | Rule | Final Rule | 2008-11-10T05:00:00Z | 2008 | 11 | 2008-11-10T05:00:00Z | 2016-03-04T16:13:54Z | E8-26825 | 0 | 0 | 09000064807a13e7 | |
| FDA-2002-N-0233-0212 | FDA | Bioterrorism; Prior Notice of Imported Food Shipments FDA-2002-N-0233 | Prior Notice of Imported Food Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002; Availability | Rule | NFR-Notice of Final Rule | 2008-11-07T05:00:00Z | 2008 | 11 | 2011-06-11T16:25:54Z | E8-26282 | 0 | 0 | 090000648079c41b | ||
| FDA-2008-N-0039-0077 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Firocoxib Tablets | Rule | Final Rule | 2008-10-31T04:00:00Z | 2008 | 10 | 2013-07-10T18:54:17Z | E8-26020 | 0 | 0 | 090000648078769c | ||
| FDA-2003-F-0398-0002 | FDA | Safe use of Conjugated linoleic acid in animal feed FDA-2003-F-0398 | Food Additives Permitted in Feed and Drinking Water of Animals; Methyl Esters of Conjugated Linoleic Acid (Cis-9, Trans-11 and Trans- 10, Cis-12-Octadecadienoic Acids) | Rule | NFR-Notice of Final Rule | 2008-10-29T04:00:00Z | 2008 | 10 | 2008-10-29T04:00:00Z | 2008-12-30T04:59:59Z | 2008-12-29T12:14:30Z | E8-25719 | 0 | 0 | 0900006480782b85 |
| FDA-2003-N-0313-0008 | FDA | Toll-Free Number for Reporting Adverse Events on Labeling for Human Drug Products FDA-2003-N-0313 | Toll-Free Number for Reporting Adverse Events on Labeling for Human Drug Products; Final Rule | Rule | Final Rule | 2008-10-28T04:00:00Z | 2008 | 10 | 2008-10-28T04:00:00Z | 2016-02-09T17:49:24Z | E8-25670 | 0 | 0 | 0900006480780764 | |
| FDA-2002-N-0031-0130 | FDA | Animal Proteins Prohibited in Ruminant Feed FDA-2002-N-0031 | Substances Prohibited From Use in Animal Food or Feed; Correction | Rule | NCR-Notice of Correction | 2008-10-23T04:00:00Z | 2008 | 10 | 2011-06-11T16:25:52Z | E8-25346 | 0 | 0 | 090000648077424d | ||
| FDA-1985-P-0452-0009 | FDA | Reclassification Petition Under 513(E) for Automated Heparin Analyzer FDA-1985-P-0452 | Medical Devices; Reclassification of the Automated Heparin Analyzer | Rule | NFR-Notice of Final Rule | 2008-10-12T04:00:00Z | 2008 | 10 | 2008-10-12T04:00:00Z | 2008-10-12T18:23:02Z | 0 | 0 | 09000064805b76eb | ||
| FDA-1978-N-1980-0002 | FDA | Medical Devices; Classification of Heparin Assays FDA-1978-N-1980 | Hematology and Pathology Devices; Classification of Heparin Assays | Rule | NFR-Notice of Final Rule | 2008-10-12T04:00:00Z | 2008 | 10 | 2008-10-12T04:00:00Z | 1980-10-15T03:59:59Z | 2008-10-12T19:10:36Z | 0 | 0 | 09000064805a1af8 | |
| FDA-2008-N-0039-0071 | FDA | FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Tulathromycin | Rule | Final Rule | 2008-10-08T04:00:00Z | 2008 | 10 | 2008-10-08T04:00:00Z | 2013-07-10T18:24:50Z | E8-23832 | 0 | 0 | 090000648073e0bc | |
| FDA-2008-N-0148-0004 | FDA | FDA-2008-N-0148 | Medical Devices; Hearing Aids; Technical Data Amendments; Confirmation of Effective Date | Rule | NCD-Notice of Confirmation of Effective Date | 2008-10-08T04:00:00Z | 2008 | 10 | 2008-10-08T04:00:00Z | 2008-10-08T13:24:08Z | E8-23717 | 0 | 0 | 090000648073e1b1 | |
| FDA-2008-N-0039-0075 | FDA | FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Crystalline Free Acid | Rule | Final Rule | 2008-10-08T04:00:00Z | 2008 | 10 | 2008-10-08T04:00:00Z | 2013-07-10T19:01:42Z | E8-23830 | 0 | 0 | 090000648073e103 | |
| FDA-2008-N-0039-0073 | FDA | FDA-2008-N-0039 | New Animal Drugs for Use in Animal Feeds; Fenbendazole | Rule | Final Rule | 2008-10-08T04:00:00Z | 2008 | 10 | 2008-10-08T04:00:00Z | 2013-07-10T20:10:36Z | E8-23845 | 0 | 0 | 090000648073e0ff | |
| FDA-1978-N-0630-0002 | FDA | Automated Heparin Analyzer FDA-1978-N-0630 | Hematology and Pathology Devices Classification of Automated Heparin Analyzers | Rule | NFR-Notice of Final Rule | 2008-10-01T04:00:00Z | 2008 | 10 | 2008-10-01T04:00:00Z | 1980-10-15T03:59:59Z | 2008-10-02T00:26:56Z | 0 | 0 | 0900006480578f48 | |
| FDA-2008-N-0341-0001 | FDA | FDA-2008-N-0341 | Applications for Food and Drug Administration Approval to Market a New Drug; Postmarketing Reports; Reporting Information About Authorized Generic Drugs | Rule | NFR-Notice of Final Rule | 2008-09-29T04:00:00Z | 2008 | 9 | 2008-09-29T04:00:00Z | 2008-12-16T04:59:59Z | 2009-02-06T16:52:46Z | E8-22833 | 0 | 0 | 090000648072c51b |
| FDA-2004-P-0205-0006 | FDA | Vitamin D & Calcium & Reduced Risk of Osteoporosis FDA-2004-P-0205 | Food Labeling: Health Claims; Calcium and Osteoporosis, and Calcium, Vitamin D, and Osteoporosis | Rule | NFR-Notice of Final Rule | 2008-09-29T04:00:00Z | 2008 | 9 | 2008-09-29T04:00:00Z | 2008-09-29T12:17:32Z | E8-22730 | 0 | 0 | 090000648072c5fe | |
| FDA-2008-N-0423-0002 | FDA | FDA-2008-N-0423 | FDA Regulations; Technical Amendment; Correction | Rule | NCR-Notice of Correction | 2008-09-19T04:00:00Z | 2008 | 9 | 2008-09-19T12:16:15Z | E8-21966 | 0 | 0 | 090000648070f519 | ||
| FDA-2008-N-0310-0004 | FDA | FDA-2008-N-0310 | Medical Devices; Medical Device Reporting; Baseline Reports; Confirmationof Effective Date | Rule | NCD-Notice of Confirmation of Effective Date | 2008-09-17T04:00:00Z | 2008 | 9 | 2008-09-17T04:00:00Z | 2008-09-17T14:00:36Z | E8-21756 | 0 | 0 | 090000648070a66c | |
| FDA-2008-N-0039-0070 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Sulfadiazine/Pyrimethamine Suspension | Rule | Final Rule | 2008-09-17T04:00:00Z | 2008 | 9 | 2008-09-17T04:00:00Z | 2013-07-10T18:41:20Z | E8-21625 | 0 | 0 | 090000648070a75b | |
| FDA-2003-N-0427-0093 | FDA | Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals FDA-2003-N-0427 | Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals | Rule | NFR-Notice of Final Rule | 2008-09-08T04:00:00Z | 2008 | 9 | 2008-09-08T04:00:00Z | 2008-09-08T12:08:38Z | E8-20779 | 0 | 0 | 09000064806f82c7 | |
| FDA-2007-N-0379-0007 | FDA | FDA-2007-N-0379 | Amendments to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals | Rule | Final Rule | 2008-09-08T04:00:00Z | 2008 | 9 | 2025-07-28T22:46:26Z | E8-20709 | 0 | 0 | 09000064806f8324 | ||
| FDA-1999-F-2405-0005 | FDA | Use of Ionizing Radiation for the Control of Food-Borne Pathogens and Infectious Protozoa, and Extension of Shelf-Life, in a Variety of Human Foods. FDA-1999-F-2405 | Irradiation in the Production, Processing and Handling of Food | Rule | NFR-Notice of Final Rule | 2008-08-22T04:00:00Z | 2008 | 8 | 2008-08-22T04:00:00Z | 2008-09-23T03:59:59Z | 2015-09-17T01:30:21Z | E8-19573 | 0 | 0 | 09000064806d2f95 |
| FDA-2008-N-0032-0031 | FDA | FDA-2008-N-0032 | Supplemental Applications Proposing Labeling Changes for Approved Drugs, Biologics, and Medical Devices | Rule | NFR-Notice of Final Rule | 2008-08-22T04:00:00Z | 2008 | 8 | 2011-06-11T16:27:11Z | E8-19572 | 0 | 0 | 09000064806d303d | ||
| FDA-2008-N-0326-0049 | FDA | FDA-2008-N-0326 | New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition; Extension of Comment Period; Delay of Effective Date of Final Rule | Rule | Delay of Effective Date | 2008-08-18T04:00:00Z | 2008 | 8 | 2008-08-18T04:00:00Z | 2008-11-04T04:59:59Z | 2012-01-27T23:43:15Z | E8-18967 | 0 | 0 | 09000064806ca625 |
| FDA-2008-N-0039-0064 | FDA | FDA-2008-N-0039 | New Animal Drugs For Use in Animal Feeds; Oxytetracycline | Rule | Final Rule | 2008-08-07T04:00:00Z | 2008 | 8 | 2013-07-11T13:44:20Z | E8-18129 | 0 | 0 | 09000064806b4074 | ||
| FDA-2008-N-0039-0060 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Amprolium | Rule | Final Rule | 2008-08-06T04:00:00Z | 2008 | 8 | 2008-08-06T04:00:00Z | 2013-07-11T14:22:57Z | E8-18093 | 0 | 0 | 09000064806b15a2 | |
| FDA-2008-N-0039-0061 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Oxfendazole Suspension | Rule | Final Rule | 2008-08-06T04:00:00Z | 2008 | 8 | 2008-08-06T04:00:00Z | 2013-07-10T19:50:02Z | E8-18092 | 0 | 0 | 09000064806b161e | |
| FDA-2008-N-0039-0062 | FDA | FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Hydrochloride | Rule | Final Rule | 2008-08-06T04:00:00Z | 2008 | 8 | 2008-08-06T04:00:00Z | 2013-07-10T16:28:17Z | E8-18094 | 0 | 0 | 09000064806b166e | |
| FDA-2005-N-0170-0005 | FDA | Current Good Manufacturing Practice Regulation and Investigational New Drugs FDA-2005-N-0170 | Current Good Manufacturing Practice and Investigational New Drugs Intended for Use in Clinical Trials; Final Rule | Rule | Final Rule | 2008-07-15T04:00:00Z | 2008 | 7 | 2008-07-15T04:00:00Z | 2024-11-12T04:18:20Z | E8-16011 | 1 | 0 | 090000648067534f | |
| FDA-2008-N-0326-0001 | FDA | FDA-2008-N-0326 | New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition | Rule | NFR-Notice of Final Rule | 2008-07-03T04:00:00Z | 2008 | 7 | 2008-07-03T04:00:00Z | 2008-09-04T03:59:59Z | 2012-07-05T02:02:01Z | E8-15052 | 0 | 0 | 0900006480653961 |
| FDA-2008-N-0039-0059 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Sulfachlorpyridazine Powder | Rule | Final Rule | 2008-06-24T04:00:00Z | 2008 | 6 | 2008-06-24T04:00:00Z | 2013-07-11T14:16:03Z | E8-14291 | 0 | 0 | 0900006480639a99 | |
| FDA-2008-N-0039-0058 | FDA | FDA-2008-N-0039 | New Animal Drugs; Change of Sponsors Drug Labeler Code | Rule | Final Rule | 2008-06-23T04:00:00Z | 2008 | 6 | 2008-06-23T04:00:00Z | 2013-07-11T14:33:23Z | E8-14149 | 0 | 0 | 090000648063712a | |
| FDA-2008-N-0331-0001 | FDA | FDA-2008-N-0331 | Medical Devices; Change of Name; Technical Amendment | Rule | NFR-Notice of Final Rule | 2008-06-23T04:00:00Z | 2008 | 6 | 2008-06-23T04:00:00Z | 2008-06-23T12:17:39Z | E8-14153 | 0 | 0 | 0900006480637136 | |
| FDA-2006-N-0364-0003 | FDA | Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile FDA-2006-N-0364 | Final Rule Exceptions or Alternatives to Labeling Requirements for Products | Rule | Final Rule | 2008-06-18T04:00:00Z | 2008 | 6 | 2008-06-18T04:00:00Z | 2015-11-12T19:37:29Z | E7-25165 | 0 | 0 | 090000648062d5ec | |
| FDA-2008-N-0039-0055 | FDA | FDA-2008-N-0039 | New Animal Drugs For Use in Animal Feeds; Tylosin | Rule | Final Rule | 2008-06-17T04:00:00Z | 2008 | 6 | 2008-06-17T04:00:00Z | 2013-07-10T18:02:55Z | E8-13606 | 0 | 0 | 090000648062a67e | |
| FDA-2008-N-0039-0056 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Ivermectin Paste | Rule | Final Rule | 2008-06-17T04:00:00Z | 2008 | 6 | 2008-06-17T04:00:00Z | 2013-07-10T15:21:43Z | E8-13607 | 0 | 0 | 090000648062a642 | |
| FDA-2008-N-0039-0053 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Ivermectin, Fenbendazole, and Praziquantel Tablets | Rule | Final Rule | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-07-10T16:34:56Z | E8-13354 | 0 | 0 | 0900006480623e54 | ||
| FDA-2008-N-0039-0051 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Deracoxib | Rule | Final Rule | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-07-10T19:07:16Z | E8-13353 | 0 | 0 | 0900006480623d7e | ||
| FDA-2008-N-0039-0049 | FDA | FDA-2008-N-0039 | Notice of Approval of Supplemental New Animal Drug Application; Moxidectin | Rule | Approval | 2008-06-09T04:00:00Z | 2008 | 6 | 2008-06-09T04:00:00Z | 2013-07-10T19:13:32Z | 08-01329 | 0 | 0 | 0900006480619532 | |
| FDA-2008-N-0039-0047 | FDA | FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Butorphanol | Rule | Final Rule | 2008-06-02T04:00:00Z | 2008 | 6 | 2008-06-02T04:00:00Z | 2013-07-10T15:16:42Z | E8-12160 | 0 | 0 | 090000648060bd12 | |
| FDA-2008-N-0148-0001 | FDA | FDA-2008-N-0148 | Medical Devices; Hearing Aids; Technical Data Amendments | Rule | NFR-Notice of Final Rule | 2008-06-02T04:00:00Z | 2008 | 6 | 2008-06-02T04:00:00Z | 2008-08-19T03:59:59Z | 2008-08-18T11:10:15Z | E8-11910 | 0 | 0 | 090000648060bd39 |
| FDA-2006-P-0404-0004 | FDA | FDA-2006-P-0404 | Food Labeling: Health Claims; Dietary Noncariogenic Carbohydrate Sweeteners and Dental Caries | Rule | NFR-Notice of Final Rule | 2008-05-27T04:00:00Z | 2008 | 5 | 2008-05-27T04:00:00Z | 2008-05-27T12:02:15Z | E8-11802 | 0 | 0 | 0900006480600f81 | |
| FDA-2008-N-0039-0045 | FDA | FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Cefovecin | Rule | Final Rule | 2008-05-22T04:00:00Z | 2008 | 5 | 2008-05-22T04:00:00Z | 2013-07-09T20:04:25Z | E8-11515 | 0 | 0 | 09000064805f84e3 | |
| FDA-2008-N-0231-0001 | FDA | FDA-2008-N-0231 | Medical Devices; Immunology and Microbiology Devices; Classification of Plasmodium Species Antigen Detection Assays | Rule | NFR-Notice of Final Rule | 2008-05-20T04:00:00Z | 2008 | 5 | 2008-05-20T04:00:00Z | 2008-05-20T12:51:57Z | E8-11263 | 0 | 0 | 09000064805f479e | |
| FDA-2008-N-0039-0043 | FDA | FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Flunixin | Rule | Final Rule | 2008-05-15T04:00:00Z | 2008 | 5 | 2008-05-15T04:00:00Z | 2013-07-10T15:59:09Z | E8-10856 | 0 | 0 | 09000064805c7f71 | |
| FDA-2008-N-0152-0002 | FDA | FDA-2008-N-0152 | Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements; Technical Amendment | Rule | NFR-Notice of Final Rule | 2008-05-14T04:00:00Z | 2008 | 5 | 2008-05-14T04:00:00Z | 2011-06-11T16:27:41Z | E8-10727 | 0 | 0 | 09000064805b7e07 | |
| FDA-2008-N-0039-0041 | FDA | FDA-2008-N-0039 | Certain Other Dosage Form New Animal Drugs; Sevoflurane | Rule | Final Rule | 2008-05-07T04:00:00Z | 2008 | 5 | 2013-07-09T18:52:23Z | E8-10153 | 0 | 0 | 090000648054eee0 | ||
| FDA-2008-N-0039-0042 | FDA | FDA-2008-N-0039 | Sevoflurane; Freedom of Information Summary | Rule | Final Rule | 2008-05-07T04:00:00Z | 2008 | 5 | 2008-05-07T04:00:00Z | 2013-07-09T18:53:51Z | 0 | 0 | 090000648054f250 | ||
| FDA-2006-P-0405-0011 | FDA | FDA-2006-P-0405 | Food Labeling: Health Claims; Soluble Fiber from Certain Foods and Risk of Coronary Heart Disease | Rule | NFR-Notice of Final Rule | 2008-05-01T04:00:00Z | 2008 | 5 | 2008-05-01T21:45:54Z | E8-09590 | 0 | 0 | 090000648053f6ca | ||
| FDA-2008-N-0039-0040 | FDA | FDA-2008-N-0039 | New Animal Drugs; Change of Sponsors Name | Rule | Final Rule | 2008-04-29T04:00:00Z | 2008 | 4 | 2013-07-11T14:34:22Z | E8-09328 | 0 | 0 | 0900006480539f86 | ||
| FDA-2004-N-0061-0002 | FDA | Human Subject Protection; Foreign Clinical Studies Not Conducted Under an Investigational New Drug Application FDA-2004-N-0061 | Human Subject Protection; Foreign Clinical Studies Not Conducted Under an Investigational New Drug Application; Final Rule | Rule | Final Rule | 2008-04-28T04:00:00Z | 2008 | 4 | 2008-04-28T04:00:00Z | 2016-02-04T16:49:48Z | E8-09200 | 0 | 0 | 0900006480537f08 | |
| FDA-2002-N-0031-0110 | FDA | Animal Proteins Prohibited in Ruminant Feed FDA-2002-N-0031 | Substances Prohibited From Use in Animal Food or Feed | Rule | NFR-Notice of Final Rule | 2008-04-25T04:00:00Z | 2008 | 4 | 2011-06-11T16:25:53Z | 08-01180 | 0 | 0 | 0900006480532ba5 | ||
| FDA-2008-N-0039-0036 | FDA | FDA-2008-N-0039 | New Animal Drugs; Enrofloxacin Final Rule | Rule | Final Rule | 2008-04-23T04:00:00Z | 2008 | 4 | 2013-07-10T19:23:29Z | E8-08713 | 0 | 0 | 090000648052275b | ||
| FDA-2008-N-0039-0035 | FDA | FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Insulin | Rule | Final Rule | 2008-04-18T04:00:00Z | 2008 | 4 | 2013-07-10T18:42:50Z | E8-08347 | 0 | 0 | 0900006480511b3a | ||
| FDA-2008-N-0039-0034 | FDA | FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Florfenicol | Rule | Final Rule | 2008-04-18T04:00:00Z | 2008 | 4 | 2013-07-10T19:52:36Z | E8-08346 | 0 | 0 | 0900006480511af1 | ||
| FDA-2004-N-0188-0034 | FDA | BSE Risk Materials in Foods and Cosmetics FDA-2004-N-0188 | Use of Materials Derived From Cattle in Human Food and Cosmetics - Interim Final Rule and Request for Comments | Rule | NIR-Notice of Interim Rule | 2008-04-17T04:00:00Z | 2008 | 4 | 2008-04-17T04:00:00Z | 2008-07-17T03:59:59Z | 2011-06-11T16:25:55Z | 08-01142 | 0 | 0 | 090000648050c23c |
| FDA-2008-N-0039-0032 | FDA | FDA-2008-N-0039 | New Animal Drugs For Use in Animal Feed; Zilpaterol | Rule | Final Rule | 2008-04-10T04:00:00Z | 2008 | 4 | 2013-07-10T17:18:08Z | E8-07583 | 0 | 0 | 09000064804a32eb | ||
| FDA-2007-N-0379-0004 | FDA | FDA-2007-N-0379 | Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals; Withdrawal | Rule | Withdrawal | 2008-04-08T04:00:00Z | 2008 | 4 | 2025-07-28T22:41:09Z | E8–7107 | 0 | 0 | 0900006480472f5c | ||
| FDA-2008-N-0039-0030 | FDA | FDA-2008-N-0039 | New Animal Drugs for Use in Animal Feed; Zilpaterol; Technical Amendment | Rule | NFR-Notice of Final Rule | 2008-04-08T04:00:00Z | 2008 | 4 | 2008-04-08T04:00:00Z | 2008-04-11T22:39:13Z | E8-07307 | 0 | 0 | 090000648046e47e | |
| FDA-2008-N-0039-0029 | FDA | FDA-2008-N-0039 | Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of NADAs; Technical Amendment | Rule | Final Rule | 2008-04-04T04:00:00Z | 2008 | 4 | 2008-04-04T04:00:00Z | 2013-07-11T14:36:14Z | E8-07103 | 0 | 0 | 0900006480439f88 | |
| FDA-2008-N-0179-0001 | FDA | FDA-2008-N-0179 | Amendment to the Current Good Manufacturing Practice Regulations for Finished Pharmaceuticals; Withdrawal [Re: FDA-2007-N-0379] | Rule | Withdrawal | 2008-04-04T04:00:00Z | 2008 | 4 | 2008-04-04T04:00:00Z | 2015-12-07T14:57:09Z | E8-07107 | 0 | 0 | 0900006480439f69 | |
| FDA-2008-N-0039-0026 | FDA | FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Enrofloxacin | Rule | Final Rule | 2008-04-02T04:00:00Z | 2008 | 4 | 2013-07-10T19:26:20Z | E8-06706 | 0 | 0 | 0900006480427483 | ||
| FDA-2008-N-0039-0025 | FDA | FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Penicillin G Benzathine and Penicillin G Procaine Suspension | Rule | Final Rule | 2008-03-31T04:00:00Z | 2008 | 3 | 2013-07-11T13:26:42Z | E8-06603 | 0 | 0 | 0900006480414884 | ||
| FDA-2008-N-0039-0024 | FDA | FDA-2008-N-0039 | New Animal Drugs For Use in Animal Feed; Zilpaterol | Rule | NFR-Notice of Final Rule | 2008-03-31T04:00:00Z | 2008 | 3 | 2013-07-10T16:46:30Z | E8-06601 | 0 | 0 | 0900006480414833 | ||
| FDA-2008-N-0042-0003 | FDA | FDA-2008-N-0042 | Civil Money Penalties Hearings; Maximum Penalty Amounts; Technical Amendment | Rule | NFR-Notice of Final Rule | 2008-03-26T04:00:00Z | 2008 | 3 | 2008-04-11T22:39:24Z | E8-06082 | 0 | 0 | 09000064804092ec | ||
| FDA-2008-N-0160-0001 | FDA | FDA-2008-N-0160 | Registration of Food Facilities Under the Public Health Security and Bioterrorism Preparedness and Response Act of 2002; Technical Amendment | Rule | NFR-Notice of Final Rule | 2008-03-26T04:00:00Z | 2008 | 3 | 2008-04-11T22:39:39Z | E8-06052 | 0 | 0 | 090000648040928e | ||
| FDA-2008-N-0039-0022 | FDA | FDA-2008-N-0039 | New Animal Drugs for Use in Animal Feeds; Bacitracin Methylene Disalicylate and Nicarbazin | Rule | Final Rule | 2008-03-26T04:00:00Z | 2008 | 3 | 2013-07-10T17:51:33Z | E8-06063 | 0 | 0 | 090000648040922b | ||
| FDA-2008-N-0042-0002 | FDA | FDA-2008-N-0042 | New Animal Drugs for Use in Animal Feed; Pyrantel; Technical Amendment | Rule | NFR-Notice of Final Rule | 2008-03-25T04:00:00Z | 2008 | 3 | 2008-03-25T04:00:00Z | 2008-04-11T22:39:23Z | E8-05928 | 0 | 0 | 090000648040797f | |
| FDA-2008-N-0039-0021 | FDA | FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Oxytetracycline Solution | Rule | Final Rule | 2008-03-20T04:00:00Z | 2008 | 3 | 2013-07-10T19:19:30Z | E8-05598 | 0 | 0 | 0900006480400974 | ||
| FDA-2008-N-0039-0019 | FDA | FDA-2008-N-0039 | New Animal Drugs for Use in Animal Feed; Zilpaterol | Rule | Final Rule | 2008-03-18T04:00:00Z | 2008 | 3 | 2013-07-10T17:55:05Z | E8-05450 | 0 | 0 | 09000064803fc2e6 | ||
| FDA-2008-N-0039-0018 | FDA | FDA-2008-N-0039 | New Animal Drugs; Change of Sponsors Name; Iron Injection; Technical Amendment | Rule | Final Rule | 2008-03-18T04:00:00Z | 2008 | 3 | 2013-07-11T12:54:27Z | E8-05452 | 0 | 0 | 09000064803fc3f3 | ||
| FDA-2008-N-0039-0017 | FDA | FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Penicillin G Procaine Aqueous Suspension | Rule | Final Rule | 2008-03-17T04:00:00Z | 2008 | 3 | 2008-03-17T04:00:00Z | 2013-07-11T13:42:23Z | E8-05217 | 0 | 0 | 09000064803faa5f | |
| FDA-2008-N-0152-0001 | FDA | FDA-2008-N-0152 | Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements; Technical Amendment | Rule | NFR-Notice of Final Rule | 2008-03-12T04:00:00Z | 2008 | 3 | 2011-06-11T16:27:41Z | E8-04870 | 0 | 0 | 09000064803f25cf | ||
| FDA-2008-N-0039-0016 | FDA | FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Change of Sponsor; Ferric Oxide Injection; Gleptoferron Injection; Iron Dextran Complex Injection; Iron Hydrogenated Dextran Injection | Rule | Final Rule | 2008-03-10T04:00:00Z | 2008 | 3 | 2008-03-10T04:00:00Z | 2013-07-11T14:40:49Z | E8-04603 | 0 | 0 | 09000064803ef1ac | |
| FDA-2008-N-0039-0015 | FDA | FDA-2008-N-0039 | Intramammary Dosage Forms; Cephapirin Benzathine | Rule | Final Rule | 2008-03-07T05:00:00Z | 2008 | 3 | 2008-03-07T05:00:00Z | 2013-07-11T12:48:12Z | E8-04473 | 0 | 0 | 09000064803eace5 | |
| FDA-2008-N-0135-0001 | FDA | FDA-2008-N-0135 | Revision of the Requirements for Live Vaccine Processing; Confirmation of Effective Date | Rule | NCD-Notice of Confirmation of Effective Date | 2008-03-07T05:00:00Z | 2008 | 3 | 2008-03-07T05:00:00Z | 2024-11-07T21:51:09Z | E8-04471 | 1 | 0 | 09000064803eac81 | |
| FDA-2008-N-0039-0013 | FDA | FDA-2008-N-0039 | New Animal Drugs; Albendazole | Rule | Final Rule | 2008-02-29T05:00:00Z | 2008 | 2 | 2013-07-11T12:43:54Z | E8-03877 | 0 | 0 | 09000064803d5031 | ||
| FDA-2008-P-0090-0001 | FDA | FDA-2008-P-0090 | Food Labeling: Health Claims; Soluble Fiber From Certain Foods and Risk of Coronary Heart Disease | Rule | NIR-Notice of Interim Rule | 2008-02-25T05:00:00Z | 2008 | 2 | 2008-02-25T05:00:00Z | 2008-05-13T03:59:59Z | 2011-06-11T16:27:55Z | E8-03418 | 0 | 0 | 09000064803c32fb |
| FDA-2008-N-0039-0011 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Altrenogest | Rule | Final Rule | 2008-02-21T05:00:00Z | 2008 | 2 | 2008-02-21T05:00:00Z | 2013-07-11T12:41:07Z | E8-03265 | 0 | 0 | 09000064803b9f24 | |
| FDA-2008-N-0039-0010 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Ivermectin Liquid | Rule | NFR-Notice of Final Rule | 2008-02-21T05:00:00Z | 2008 | 2 | 2008-02-21T05:00:00Z | 2013-07-10T15:41:57Z | E8-03266 | 0 | 0 | 09000064803b9f98 | |
| FDA-2008-N-0068-0001 | FDA | FDA-2008-N-0068 | Generally Recognized As Safe Substances; Technical Amendments | Rule | ND-Notice of Denial | 2008-02-14T05:00:00Z | 2008 | 2 | 2008-02-14T05:00:00Z | 2008-11-17T22:43:38Z | E8-02809 | 0 | 0 | 09000064803ae9eb | |
| FDA-2008-N-0039-0009 | FDA | FDA-2008-N-0039 | New Animal Drugs; Change of Sponsor; Ketamine | Rule | Final Rule | 2008-02-13T05:00:00Z | 2008 | 2 | 2008-02-13T05:00:00Z | 2013-07-10T16:07:12Z | E8-02607 | 0 | 0 | 09000064803adb81 | |
| FDA-2008-N-0039-0008 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Phenylbutazone Tablets | Rule | Final Rule | 2008-02-13T05:00:00Z | 2008 | 2 | 2008-02-13T05:00:00Z | 2013-07-11T13:04:52Z | E8-02608 | 0 | 0 | 09000064803adadb | |
| FDA-2008-N-0039-0007 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs: Spectinomycin | Rule | NFR-Notice of Final Rule | 2008-02-05T05:00:00Z | 2008 | 2 | 2008-04-11T22:39:13Z | E8-02065 | 0 | 0 | 09000064803a8563 | ||
| FDA-2008-N-0075-0001 | FDA | FDA-2008-N-0075 | Skin Protectant Drug Products for Over-the-Counter Human Use; Reduced Labeling; Technical Amendment | Rule | NFR-Notice of Final Order | 2008-02-01T05:00:00Z | 2008 | 2 | 2008-02-01T05:00:00Z | 2011-06-11T16:27:38Z | E8-01818 | 0 | 0 | 09000064803a6435 | |
| FDA-2008-N-0039-0005 | FDA | FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Tulathromycin | Rule | Final Rule | 2008-02-01T05:00:00Z | 2008 | 2 | 2008-02-01T05:00:00Z | 2013-07-10T18:34:59Z | E8-01906 | 0 | 0 | 09000064803a6488 | |
| FDA-2008-N-0039-0003 | FDA | FDA-2008-N-0039 | New Animal Drugs For Use in Animal Feed; Zilpaterol | Rule | Final Rule | 2008-02-01T05:00:00Z | 2008 | 2 | 2008-02-01T05:00:00Z | 2013-07-11T14:38:03Z | E8-01903 | 0 | 0 | 09000064803a642e | |
| FDA-2008-N-0039-0002 | FDA | FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Clindamycin | Rule | Final Rule | 2008-01-24T05:00:00Z | 2008 | 1 | 2008-01-24T05:00:00Z | 2013-07-09T20:13:31Z | E8-01199 | 0 | 0 | 09000064803a17e1 | |
| FDA-2008-N-0042-0001 | FDA | FDA-2008-N-0042 | Human Cells, Tissues, and Cellular and Tissue-Based Products | Rule | NFR-Notice of Final Rule | 2008-01-18T05:00:00Z | 2008 | 1 | 2008-01-18T05:00:00Z | 2008-11-17T19:37:28Z | 08-55500 | 0 | 0 | 090000648039d570 | |
| FDA-2008-N-0039-0001 | FDA | FDA-2008-N-0039 | Intramammary Dosage Forms; Cephapirin Sodium | Rule | Final Rule | 2008-01-17T05:00:00Z | 2008 | 1 | 2008-01-17T05:00:00Z | 2013-07-11T13:00:09Z | E8-00816 | 0 | 0 | 090000648039c6a6 | |
| FDA-2008-N-0034-0001 | FDA | FDA-2008-N-0034 | Oral Dosage Form New Animal Drugs; Firocoxib Tablets | Rule | NFR-Notice of Final Rule | 2008-01-16T05:00:00Z | 2008 | 1 | 2008-01-16T05:00:00Z | 2008-11-21T21:01:33Z | E8-00730 | 0 | 0 | 090000648039b8a9 | |
| FDA-2008-N-0035-0001 | FDA | FDA-2008-N-0035 | Implantation or Injectable Dosage Form New Animal Drugs; Flunixin | Rule | NFR-Notice of Final Rule | 2008-01-16T05:00:00Z | 2008 | 1 | 2008-01-16T05:00:00Z | 2008-11-21T21:53:25Z | E8-00699 | 0 | 0 | 090000648039b8bd |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);